Windlas Biotech Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Windlas Biotech (WINDLAS) Key Ratios
Windlas Biotech Share Price Analysis Local DB
Windlas Biotech share price is ₹1,096.60, day high (share price) is ₹1,110.00, day low (share price) is ₹1,003.05 and volume is 1,564,975. 52 Week high share price for Windlas Biotech is ₹1,110.00 on 02 Sep 2026 and 52 week low share price for Windlas Biotech is ₹697.40 on 16 Mar 2026. Price data as of: 02 Sep, 2026 3:31 PM.
According to latest price data (as of 02 Sep, 2026 3:31 PM) for Windlas Biotech share, 14 day period RSI (Relative Strength Index) is 76.8 (O.Bought), 50 DMA (50 Displaced Moving Average) is 897.14 and 200 DMA (200 Displaced Moving Average) is 822.60.
Windlas Biotech (WINDLAS) Technical Analysis
Windlas Biotech Technical Data and Analysis available in multiple timeframes.
Windlas Biotech Oscillators Analysis
Windlas Biotech Price Action
Windlas Biotech Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 76.83 |
| Stoch %K (14, 3, 3) | 82.09 |
| CCI (20) | 170.50 |
| ADX (14) | 36.84 |
| Awesome Osc | 92.11 |
| Momentum (10) | 131.65 |
| MACD (12, 26, 9) | 42.04 |
| MACD Signal | 34.08 |
| Stoch RSI (14) | 93.31 |
| Williams %R (14) | -6.77 |
| Bull/Bear Power | 130.63 |
| Ultimate Osc | 55.48 |
| MFI (14) | 92.45 |
| ROC (21) | 27.18 |
| ROC (125) | 45.25 |
| ATR (14) | 45.14 |
Windlas Biotech Moving Averages
| Ichimoku Base | 959.03 | Above Base |
| VWMA (20) | 987.00 | Above VWMA |
| HMA (9) | 1,033.23 | Above HMA |
Windlas Biotech Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
- MACD is above the signal line and in positive territory, reflecting supportive momentum.
WEAKNESSES
- No notable technical weakness signals are currently observed.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- RSI is overbought, which may increase the likelihood of short-term consolidation or pullback.
- Price is near the upper Bollinger Band, which can indicate strong momentum or possible exhaustion.
Windlas Biotech Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 1,050.68 | 1,062.58 | 1,016.56 | 1,033.32 |
| Resistance 2 | 1,033.32 | 1,039.26 | 1,013.82 | 1,021.91 |
| Resistance 1 | 1,020.83 | 1,032.73 | 1,011.09 | 1,014.87 |
| Pivot Point | 1,003.47 | 1,009.41 | 1,008.35 | 1,003.47 |
| Support 1 | 990.98 | 1,002.88 | 1,005.61 | 992.06 |
| Support 2 | 973.62 | 979.56 | 1,002.88 | 985.02 |
| Support 3 | 961.13 | 973.03 | 1,000.14 | 973.62 |
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Windlas Biotech - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | May 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 63.31% | 63.31% | 61.90% | 61.99% |
| FII | 2.04% | 0.99% | 0.60% | 0.93% |
| DII (Other) | 4.09% | 3.79% | 4.73% | 4.81% |
| Retail & Others | 24.80% | 25.50% | 25.70% | 25.64% |
| Mutual Funds | 5.76% | 6.41% | 7.08% | 6.63% |
Windlas Biotech - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 921.89 +18.51% | 86.98 +9.05% | 66.46 +8.97% |
| Mar 2025 | 777.90 +20.71% | 79.76 +3.46% | 60.99 +4.81% |
| Mar 2024 | 644.43 +23.21% | 77.09 +35.15% | 58.19 +36.5% |
| Mar 2023 | 523.05 | 57.04 | 42.63 |
Windlas Biotech - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 16 Jul 2026 | ₹6.3 | View Details |
|
Announcement date
21 May 2026
Ex dividend date
16 Jul 2026
Record date
16 Jul 2026
Dividend type
Final
Amount
6.3
Dividend %
126.0
Details
Rs.6.3000 per share(126%)Final Dividend
|
|||
